GBSCHWARTZ.COM
Updated 563 days ago
Routinely charged with major business re-organizations and turnarounds by establishing disciplined departments built on best practices in operations, processes, and capabilities that improved margins and cash flow through consummate 10-figure P&L ($1B+) execution and financial planning... Progressive-thinking, synergistic growth leader who leads by example, quickly assesses obstacles to stalled growth and identifies untapped opportunities that enable lasting organizational turnarounds + drive millions in incremental revenue/profit/EBITDA. Record of formulating and executing game-changing strategies that outshine competition across high growth Life Science markets ranging from early-stage discovery, through to BioPharma manufacturing to Clinical Diagnostics. Credited for success in building c-suite and Board consensus to drive forward change agendas and enable strategic roadmaps that deliver short- and long-term results. Respected for trimming millions in operational costs and..